Close

Ratings by UBS (Eliana Merle)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/21/2024 Rapt Therapeutics RAPT Downgrade Neutral
(Buy)
6.87
(8.72)
26.93% Details
2/14/2024 CymaBay Therapeutic CBAY Downgrade Neutral
(Buy)
32.21
(32.23)
0.06% Details
12/21/2023 Kodiak Sciences Inc. KOD Maintain Neutral
(N/A)
 
 
  Details
11/28/2023 Zentalis Pharmaceuticals ZNTL Maintain Buy
(N/A)
 
 
  Details
11/6/2023 Moderna MRNA Maintain Buy
(N/A)
 
 
  Details
11/2/2023 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
 
 
  Details
11/1/2023 AnaptysBio ANAB Maintain Neutral
(N/A)
 
 
  Details
10/23/2023 Moderna MRNA Maintain Buy
(N/A)
 
 
  Details
10/12/2023 89bio Inc. ETNB Maintain Buy
(N/A)
 
 
  Details
10/12/2023 Akero Therapeutics AKRO Maintain Buy
(N/A)
 
 
  Details
9/18/2023 BioMarin Pharmaceutical Inc. BMRN New Coverage Buy
(N/A)
87.68
(91.24)
4.06% Details
8/28/2023 89bio Inc. ETNB New Coverage Buy
(N/A)
16.52
(11.18)
-32.32% Details
8/28/2023 Akero Therapeutics AKRO New Coverage Buy
(N/A)
47.97
(25.34)
-47.18% Details
8/14/2023 CymaBay Therapeutic CBAY New Coverage Buy
(N/A)
12.96
(32.23)
148.69% Details
7/27/2023 Kodiak Sciences Inc. KOD Downgrade Neutral
(Buy)
3.63
(5.30)
46.01% Details
6/26/2023 Moderna MRNA Upgrade Buy
(Neutral)
120.48
(96.46)
-19.94% Details
5/19/2023 uniQure BV QURE Maintain Buy
(N/A)
 
 
  Details
5/17/2023 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
5/3/2023 Iveric Bio ISEE Downgrade Neutral
(Buy)
38.05
(39.95)
4.99% Details
3/15/2023 Rapt Therapeutics RAPT Maintain Buy
(N/A)
 
 
  Details
12/7/2022 Gossamer Bio Inc. GOSS Maintain Buy
(N/A)
 
 
  Details
11/23/2022 uniQure BV QURE Maintain Buy
(N/A)
 
 
  Details
11/18/2022 Zentalis Pharmaceuticals ZNTL Maintain Buy
(N/A)
 
 
  Details
10/18/2022 Iveric Bio ISEE Maintain Buy
(N/A)
 
 
  Details
8/2/2022 Iveric Bio ISEE New Coverage Buy
(N/A)
10.51
(39.95)
280.11% Details
4/6/2022 Gossamer Bio Inc. GOSS New Coverage Buy
(N/A)
8.75
(1.30)
-85.14% Details
3/17/2022 uniQure BV QURE Upgrade Buy
(Neutral)
15.89
(6.32)
-60.23% Details
1/21/2022 Moderna MRNA New Coverage Neutral
(N/A)
167.52
(96.46)
-42.42% Details
1/5/2022 BridgeBio Pharma BBIO Maintain Buy
(N/A)
 
 
  Details
5/21/2021 Zentalis Pharmaceuticals ZNTL New Coverage Buy
(N/A)
55.09
(13.64)
-75.24% Details
5/21/2021 Kadmon Holdings KDMN New Coverage Buy
(N/A)
3.75
(9.50)
153.33% Details
5/21/2021 Kymera Therapeutics KYMR New Coverage Buy
(N/A)
40.10
(41.84)
4.34% Details
5/21/2021 AnaptysBio ANAB New Coverage Neutral
(N/A)
24.55
(25.87)
5.38% Details
5/21/2021 BridgeBio Pharma BBIO New Coverage Buy
(N/A)
54.97
(34.00)
-38.15% Details
5/21/2021 Arvinas Inc. ARVN New Coverage Buy
(N/A)
63.79
(47.00)
-26.32% Details
5/21/2021 uniQure BV QURE New Coverage Neutral
(N/A)
32.79
(6.32)
-80.73% Details